Sector
PharmaceuticalsOpen
₹412Prev. Close
₹408.25Turnover(Lac.)
₹560.62Day's High
₹416Day's Low
₹406.7552 Week's High
₹581.952 Week's Low
₹130Book Value
₹47.72Face Value
₹1Mkt Cap (₹ Cr.)
2,514.96P/E
0EPS
0Divi. Yield
024 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
17 Sep 2024
12:00 AM
AGM
Announcement Date: 17 Sep, 2024
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 27.78 | 27.78 | 27.78 | 27.78 |
Preference Capital | 5.99 | 4.98 | 0 | 0 |
Reserves | 301.36 | 297.87 | 387.32 | 480.39 |
Net Worth | 335.13 | 330.63 | 415.1 | 508.17 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 343.55 | 158.08 | 576.56 | 530.08 |
yoy growth (%) | 117.32 | -72.58 | 8.76 | -18.05 |
Raw materials | -176.26 | -58.52 | -196.99 | -168.83 |
As % of sales | 51.3 | 37.02 | 34.16 | 31.84 |
Employee costs | -59.47 | -46.64 | -136.73 | -132.2 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -12.85 | -63.52 | -61.23 | -46.5 |
Depreciation | -26.57 | -26.9 | -57.04 | -66.14 |
Tax paid | -1.56 | -17.09 | -10.64 | 11.38 |
Working capital | -357.74 | 386.41 | -54.89 | 14.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 117.32 | -72.58 | 8.76 | -18.05 |
Op profit growth | -100.78 | -176.42 | 17.18 | -38.24 |
EBIT growth | -90.84 | -238.73 | -26.33 | -14.6 |
Net profit growth | -90.56 | 112.96 | -1.08 | -8,451.83 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 559.09 | 559.17 | 459.95 | 661.23 | 624.81 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 559.09 | 559.17 | 459.95 | 661.23 | 624.81 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 56.65 | 61.83 | 154.32 | 1,687.18 | 10.06 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Rajesh Jain
Joint Managing Director
Sandeep Jain
Group CFO & Company Secretary
Vinod Goel
Non-Exec. & Independent Dir.
Mukul Gupta
Whole-time Director
Ankesh Jain
Non-Exec. & Independent Dir.
BHUPINDER SINGH
Independent Director
Ambika Sharma
Non Executive Director
Krishan Kumar Jalan
Non Executive Director
Rajender Pal Singh
Whole Time Director
Harshet Jain
Whole Time Director
Sanjay Trehan
Independent Director
Venkatesh Sarvasiddhi
Ambala-Chandigarh Highway,
Punjab - 140501
Tel: 91-1762-505900
Website: http://www.panaceabiotec.com
Email: corporate@panaceabiotec.com; investorgrievances@pa
D-153/A 1st Flr,
Okhla Industrial Are, Phase-I,
New Delhi-110020
Tel: 91-11-26812682
Website: www.skylinerta.com
Email: admin@skylinerta.com/virenr@skylinerta.com
Summary
Indias leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporat...
Read More
Reports by Panacea Biotec Ltd
What is the Panacea Biotec Ltd share price today?
What is the Market Cap of Panacea Biotec Ltd?
What is the PE and PB ratio of Panacea Biotec Ltd?
What is the 52 Week High and Low of Panacea Biotec Ltd?
What is the CAGR of Panacea Biotec Ltd?
What is the shareholding pattern of Panacea Biotec Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
